# Grand Yangtze Capital

> Grand Yangtze Capital is a VC fund backing Manufacturing and Biotechnology. See 31 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 31
- Last investment: Jun 2024
- Lead investor: 23%
- Fund size: $88M
- Last fund: Dec 2018
- Last updated: Aug 2026
- Website: http://www.grandyangtze.com/

Grand Yangtze Capital is an investment firm focused principally on equity investments in growth and expansion stage enterprises in China. They have been managing 7 PE and VC funds since 2007 and have deployed over 4 billion RMB. Grand Yangtze Capital has invested in over 40 companies, among which 8 companies went public, and several others weremerged or acquired, e.g. Sino-Crystal (300064), Shuanghuan(002472), Hainan Rubber(601118), HLBN(300291), ZMJ(601717), China UMS, ZBT Pharma, ELLASSAY(603808), B-Soft(300451), Guochuang Software(300520), YMatou, Pharma Block, etc.

## Contacts

5 contacts available for Grand Yangtze Capital. Shizune tracks 1 team members at Grand Yangtze Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/grand-yangtze-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 10 | 32% |
| Biotechnology | 4 | 13% |
| Software | 3 | 10% |
| Health Care | 3 | 10% |
| Finance | 2 | 6% |

50 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 12 | 39% |
| Series B | 9 | 29% |
| Angel | 3 | 10% |
| Funding Round | 2 | 6% |
| Series C | 1 | 3% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 27 | 87% |
| United States | 1 | 3% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Chunyi Li | Founding Partner, President | 0 | https://shizune.co/investors/profile/chunyi-li |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Chengdu Pukang Biotechnology Co. | Chengdu Pukang Biotechnology Co., Ltd specializes in the development, production, and supply of high-purity single molecular PEG series derivatives, polypeptide long-acting drug side chains, and their intermediates. The company focuses on serving the pharmaceutical industry with a range of chemical supplies that are crucial for drug development andmanufacturing processes. With a professional R&D team, Chengdu Pukang Biotechnology is dedicated to advancing pharmaceutical intermediates technology and providing solutions that meet the evolving needs of the healthcare sector. The company's commitment to research and development is evident in its continuous efforts to innovate and improve its product offerings to support the pharmaceutical industry. |  | Series B | Jun 06, 2024 |  |
| Bitong Semiconductor | Bitong Semiconductor is a full-service high-tech company that specializes in installing and troubleshooting equipment. | $70.5M | Venture - Series Unknown | Nov 23, 2023 |  |
| Diallebo | Diallebo is a biotech company that focuses on R&D, manufacturing & sales of laboratory testing products for autoimmune diseases and neurological diseases. | $13.7M | Series A | Sep 15, 2023 |  |
| Eaglenos | Eaglenos is an IVD company that specialises in medical POCT, home health care devices, and health management systems. It focuses on chemistry, materials, electronics, software, machinery, and biomedical engineering. It helps in the advancement of electrochemistry, microfluidics, signal acquisition, and automation technologies. | $21.2M | Series A | May 29, 2023 |  |
| Kingdee Invoice Cloud | Kingdee Invoice Cloud focuses on controlling invoice data and managing accounting vouchers. It has developed three key cloud services, including smart bill cloud, electronic accounting file cloud, and reimbursement robot. These services make extensive use of cutting-edge technologies like artificial intelligence, blockchain, digital twins, and theInternet of Things. |  | Series A | May 18, 2023 |  |
| TBSTest Technology | Yuexin Technology is a semiconductor test equipment developer specializing in R&D, production and sales of ultra-large-scale integrated circuit test equipment (ATE). Its main product is SOC test equipment, which is mainly for enterprise users of integrated circuit design, production, packaging and testing. Integrated circuit test equipment andsolutions. | $74.7M | Series C | Jun 24, 2022 |  |
| Hai Guanjia | YunLSP is the developer of SaaS cloud collaboration systems and tools designed for the logistics enterprise system. | $15M | Series B | Jun 06, 2022 |  |
| Maibang Bio | Maibang Bio is a cell culture medium product developer, focusing on the research and development of high-end chemically defined. | $15.7M | Series B | Apr 15, 2022 |  |
| Yaotan Pharmaceutical | Yaotan Pharmaceutical is a comprehensive one-stop CDMO service provider. | $29.9M | Series A | Mar 29, 2022 |  |
| Vision Semiconductor Technology | The founding team of Vipas Semiconductor is composed of high-tech technical experts and market management experts from home and abroad. Relying on Nanjing University's independent innovation of vertical charge transfer imaging device (VPS) technology, it focuses on a new generation of new sensor imaging chip technology products. A high-techcompany that develops and manufactures. | $15.7M | Series A | Nov 29, 2021 |  |

10 of 31 investments shown.

## Co-investors
- [SDIC Venture Capital](https://shizune.co/investors/profile/sdic-venture-capital) — VC Fund, 4 deals together
- [Cowin Venture](https://shizune.co/investors/profile/cowin-venture) — VC Fund, 2 deals together
- [Huatai Zijin Investment](https://shizune.co/investors/profile/huatai-zijin-investment) — VC Fund, 2 deals together
- [InnoMed Capital](https://shizune.co/investors/profile/innomed-capital) — VC Fund, 2 deals together
- [Sangel Capital](https://shizune.co/investors/profile/sangel-capital) — VC Fund, 2 deals together
- [October Capital](https://shizune.co/investors/profile/shanghai-october-asset-management) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Coinbase Ventures](https://shizune.co/investors/profile/coinbase-ventures) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Finance Investors in China](https://shizune.co/investors/finance-investors-china)
- [Finance VC Funds in China](https://shizune.co/investors/finance-vc-funds-china)

## FAQ

### What does Grand Yangtze Capital invest in?

Grand Yangtze Capital invests primarily in Manufacturing, Biotechnology and Software startups, most often at Series A and Series B stage. Most of the 31 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Grand Yangtze Capital?

Public channels for Grand Yangtze Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Grand Yangtze Capital?

The team at Grand Yangtze Capital includes Chunyi Li (Founding Partner, President). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co